TY - JOUR
T1 - Serum polyclonal immunoglobulin free light chain levels predict mortality in people with chronic kidney disease
AU - Hutchison, Colin A
AU - Burmeister, Anne
AU - Harding, Stephen J
AU - Basnayake, Kolitha
AU - Church, Hannah
AU - Jesky, Mark D
AU - White, Katie
AU - Green, Clara E
AU - Stringer, Stephanie J
AU - Bassett, Paul
AU - Ferro, Charles J
AU - Cockwell, Paul
N1 - Copyright © 2014 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.
PY - 2014/5
Y1 - 2014/5
N2 - OBJECTIVE: To determine whether elevated serum polyclonal free light chain (FLC) levels predict mortality in a population of individuals with chronic kidney disease (CKD).PATIENTS AND METHODS: From January 2, 2006, through July 31, 2007, we recruited a cohort of 848 people with CKD who were not receiving renal replacement therapy and did not have monoclonal gammopathy. We measured serum kappa FLC and lambda FLC isotype levels to determine combined FLC (cFLC) levels. The cohort was prospectively followed up for a median of 63 months (interquartile range, 0-93 months). Cox regression analysis was performed to determine variables predictive of mortality.RESULTS: High cFLC levels were an independent risk factor for death (hazard ratio [HR], 2.71; 95% CI, 1.98-3.70; P<.001). Other independent risk factors were age (HR, 1.79; 95% CI, 1.52-2.10; P<.001), South Asian ethnicity (HR, 0.33; 95% CI, 0.14-0.64; P=.02), preexisting cardiovascular disease (HR, 1.59; 95% CI, 1.09-2.31; P=.02), and high-sensitivity C-reactive protein (HR, 1.13; 95% CI, 1.00-1.28; P=.04). Neither estimated glomerular filtration rate nor albuminuria was an independent risk factor for death.CONCLUSION: High cFLC levels independently predict mortality in people with CKD.
AB - OBJECTIVE: To determine whether elevated serum polyclonal free light chain (FLC) levels predict mortality in a population of individuals with chronic kidney disease (CKD).PATIENTS AND METHODS: From January 2, 2006, through July 31, 2007, we recruited a cohort of 848 people with CKD who were not receiving renal replacement therapy and did not have monoclonal gammopathy. We measured serum kappa FLC and lambda FLC isotype levels to determine combined FLC (cFLC) levels. The cohort was prospectively followed up for a median of 63 months (interquartile range, 0-93 months). Cox regression analysis was performed to determine variables predictive of mortality.RESULTS: High cFLC levels were an independent risk factor for death (hazard ratio [HR], 2.71; 95% CI, 1.98-3.70; P<.001). Other independent risk factors were age (HR, 1.79; 95% CI, 1.52-2.10; P<.001), South Asian ethnicity (HR, 0.33; 95% CI, 0.14-0.64; P=.02), preexisting cardiovascular disease (HR, 1.59; 95% CI, 1.09-2.31; P=.02), and high-sensitivity C-reactive protein (HR, 1.13; 95% CI, 1.00-1.28; P=.04). Neither estimated glomerular filtration rate nor albuminuria was an independent risk factor for death.CONCLUSION: High cFLC levels independently predict mortality in people with CKD.
KW - Biomarkers/blood
KW - Cause of Death
KW - Comorbidity
KW - England
KW - Female
KW - Glomerular Filtration Rate
KW - Humans
KW - Immunoglobulin Light Chains/blood
KW - Immunoglobulin kappa-Chains/blood
KW - Immunoglobulin lambda-Chains/blood
KW - Kaplan-Meier Estimate
KW - Male
KW - Middle Aged
KW - Prognosis
KW - Prospective Studies
KW - Renal Insufficiency, Chronic/blood
KW - Severity of Illness Index
U2 - 10.1016/j.mayocp.2014.01.028
DO - 10.1016/j.mayocp.2014.01.028
M3 - Article
C2 - 24797643
SN - 0025-6196
VL - 89
SP - 615
EP - 622
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 5
ER -